Related Experiment Video
Updated: Apr 24, 2026
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Robot-assisted prostatectomy in obese patients: how influential is obesity on operative outcomes?
Tianyuan Xu1, Xianjin Wang, Leilei Xia
1Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine , Shanghai, China .
Objective:
To compare operative outcomes of robot-assisted radical prostatectomy (RARP) in obese and nonobese patients with prostate cancer.
Materials And Methods:
A literature search of MEDLINE, EMBASE, Google Scholar, and the Cochrane Library was performed up to March 2014. All studies that have assessed operative outcomes of RARP in obese and nonobese patients were included. Outcome measures were perioperative and functional results, including operating time, estimated blood loss (EBL), complications, length of hospital stay (LOS), positive surgical margins (PSMs), and recovery of continence and potency. Pooled odds ratios (ORs) and weighted mean differences (WMDs) with 95% confidence intervals (CIs) were calculated using fixed-effect or random-effect model. Subgroup analysis was performed for institutions with greater experience of RARP in obese cases.
Results:
Thirteen observational studies from 12 study population were included for 1821 obese patients compared with 4801 nonobese patients. Operating time (p=0.0001; WMD: 24.28; 95% CI, 11.93-36.64) and EBL (p=0.003; WMD: 38.28; 95% CI, 13.45-63.11) were significantly increased in obese patients compared with nonobese counterparts. There was no significant difference in complications, LOS, or PSM rates. Subgroup analysis for studies that have involved ≥100 obese cases showed consistent results, but the increases in operating time (9.8 minutes; 95% CI, 1.7-18 minutes) and EBL (14 mL; 95% CI, 5.0-23 mL) were much lower compared with the original analysis. As for functional outcomes, obese patients showed significantly higher probabilities of incontinence (p=0.003; OR: 1.41; 95% CI, 1.13-1.77) and impotency (p=0.02; OR: 1.29; 95% CI, 1.03-1.61) at 1 year.
Conclusions:
Perioperative outcomes of RARP in obese patients are comparable with those in nonobese patients, except for significant but small increases in operating time and EBL. Surgeons should initiate RARP procedures in obese cases after overcoming the learning curve. Further studies should be performed to evaluate the functional outcomes for obese patients undergoing RARP.
